dolichol-monophosphate and Niemann-Pick-Diseases

dolichol-monophosphate has been researched along with Niemann-Pick-Diseases* in 2 studies

Other Studies

2 other study(ies) available for dolichol-monophosphate and Niemann-Pick-Diseases

ArticleYear
Alterations in the biosynthesis of cholesterol, dolichol and dolichyl-P in the genetic cholesterol homeostasis disorder, Niemann-Pick type C disease.
    Biochimica et biophysica acta, 1998, Nov-02, Volume: 1394, Issue:2-3

    The biosynthesis of cholesterol, dolichol and dolichyl-P were investigated in a murine model of Niemann-Pick type C disease using both in vitro and in vivo systems. In vivo incorporation of [3H]mevalonate into squalene, dolichol and dolichyl-P decreased. The amount of dolichyl-P was elevated due to a decrease in the rate of degradation. Labeling of squalene and cholesterol of liver homogenates in vitro was decreased in the diseased mice and a lowering of microsomal activities of both HMG-CoA reductase and squalene synthase were also observed. In experiments with brain homogenate, decreased [3H]mevalonate labeling of squalene, cholesterol and dolichol was found in vitro. The decreases in cis-prenyltransferase and squalene synthase activities were observed at a very early phase of the disease. In contrast to the decreased biosynthesis of cholesterol observed in vitro, the labeling of total liver cholesterol was found to be increased in Niemann-Pick type C liver upon in vivo investigation, possibly due to the accumulation of this lipid as a result of a deficient transport process. In the brain, where in vivo labeling reflects only biosynthesis, a decreased rate of cholesterol synthesis was demonstrated.

    Topics: Animals; Brain; Cholesterol; Disease Models, Animal; Dolichol Phosphates; Dolichols; Farnesyl-Diphosphate Farnesyltransferase; Hydroxymethylglutaryl CoA Reductases; Liver; Male; Mevalonic Acid; Mice; Mice, Inbred BALB C; Microsomes, Liver; Niemann-Pick Diseases; Squalene; Transferases; Tritium

1998
Changes in the levels of dolichol and dolichyl phosphate in a murine model of Niemann-Pick's type C disease.
    Journal of neurochemistry, 1995, Volume: 65, Issue:2

    The distributions of mevalonate pathway lipids in various organs of a mouse strain used as a model for Niemann-Pick's type C disease were analyzed. Extensive accumulation of cholesterol was observed in all tissues with the exception of the brain, where the content of this lipid was decreased. The changes in total dolichol contents of most organs varied from a 50% decrease in the lung to a twofold increase in kidney and heart. There was relative enrichment of longer-chain dolichols, but no increase in the relative amount of alpha-unsaturated polyprenols was observed. The levels of dolichyl phosphate in all organs were increased, and most of this lipid was associated with bound oligosaccharides or proteins. Ubiquinone levels were largely unchanged. Subfractionation studies revealed that heavy and light lysosomes exhibited a 10-fold increase in cholesterol level, the amount of dolichol was decreased in lysosomes and increased in microsomes, and there was an increase in the dolichyl phosphate levels of all three of these subfractions. These results indicate that in diseased mice cholesterol accumulation in various organs is paralleled by an increase in the dolichyl phosphate concentration, whereas dolichol transport from the endoplasmic reticulum to lysosomes is inhibited.

    Topics: Animals; Cholesterol; Dolichol Phosphates; Dolichols; Mevalonic Acid; Mice; Mice, Inbred BALB C; Microscopy, Electron; Niemann-Pick Diseases; Subcellular Fractions; Tissue Distribution; Ubiquinone

1995